Global Pandemic Influenza Vaccine Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Pandemic Influenza Vaccine Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC0882713
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The Pandemic Influenza Vaccine market was valued at US$ xx in 2023. The market for Pandemic Influenza Vaccine is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Pandemic Influenza Vaccine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pandemic Influenza Vaccine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Pandemic Influenza Vaccine market are discussed.

The market is segmented by types: 
    Influenza A (H1N1) Vaccines
    Other

It can be also divided by applications:
    Adult
    Paediatric

And this report covers the historical situation, present status and the future prospects of the global Pandemic Influenza Vaccine market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    AstraZeneca
    GlaxoSmithKline
    Novartis
    Sanofi
    Valneva
    Lupin
    Chiron Panacea
    Solvay and Serum Institute of India Pvt. Ltd.
    Sementis

Report Includes:
- xx data tables and xx additional tables
- An overview of global Pandemic Influenza Vaccine market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Pandemic Influenza Vaccine market
- Profiles of major players in the industry, including     AstraZeneca,     GlaxoSmithKline,     Novartis,     Sanofi,     Valneva.....

Research objectives
    To study and analyze the global Pandemic Influenza Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of Pandemic Influenza Vaccine market by identifying its various subsegments.
    Focuses on the key global Pandemic Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Pandemic Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Pandemic Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global Pandemic Influenza Vaccine Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 Pandemic Influenza Vaccine Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Pandemic Influenza Vaccine Industry Overview
    2.1 Global Pandemic Influenza Vaccine Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 Pandemic Influenza Vaccine Global Import Market Analysis
        2.1.2 Pandemic Influenza Vaccine Global Export Market Analysis
        2.1.3 Pandemic Influenza Vaccine Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Influenza A (H1N1) Vaccines
        2.2.2 Other
    2.3 Market Analysis by Application
        2.3.1 Adult
        2.3.2 Paediatric
    2.4 Global Pandemic Influenza Vaccine Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Pandemic Influenza Vaccine Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global Pandemic Influenza Vaccine Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Pandemic Influenza Vaccine Manufacturer Market Share
        2.4.5 Top 10 Pandemic Influenza Vaccine Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Pandemic Influenza Vaccine Market
        2.4.7 Key Manufacturers Pandemic Influenza Vaccine Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Pandemic Influenza Vaccine Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Pandemic Influenza Vaccine Industry Impact
        2.7.1 How the Covid-19 is Affecting the Pandemic Influenza Vaccine Industry
        2.7.2 Pandemic Influenza Vaccine Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Pandemic Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Pandemic Influenza Vaccine Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Pandemic Influenza Vaccine Market Size Categorized by Regions
    4.1 Global Pandemic Influenza Vaccine Revenue, Sales and Market Share by Regions
        4.1.1 Global Pandemic Influenza Vaccine Sales and Market Share by Regions (2019-2023)
        4.1.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Regions (2019-2023)
    4.2 Europe Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    4.3 APAC Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    4.4 North America Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    4.5 South America Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    4.6 Middle East & Africa Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)

5 Europe Pandemic Influenza Vaccine Market Size Categorized by Countries
    5.1 Europe Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
        5.1.1 Europe Pandemic Influenza Vaccine Sales by Countries (2019-2023)
        5.1.2 Europe Pandemic Influenza Vaccine Revenue by Countries (2019-2023)
        5.1.3 Germany Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        5.1.4 UK Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        5.1.5 France Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        5.1.6 Russia Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        5.1.7 Italy Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        5.1.8 Spain Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    5.2 Europe Pandemic Influenza Vaccine Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type (2019-2023)
        5.3.1 Europe Pandemic Influenza Vaccine Sales Market Share by Type (2019-2023)
        5.3.2 Europe Pandemic Influenza Vaccine Revenue and Revenue Share by Type (2019-2023)
    5.4 Europe Pandemic Influenza Vaccine Sales Market Share by Application (2019-2023)

6 Asia-Pacific Pandemic Influenza Vaccine Market Size Categorized by Countries
    6.1 Asia-Pacific Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Pandemic Influenza Vaccine Sales by Countries (2019-2023)
        6.1.2 Asia-Pacific Pandemic Influenza Vaccine Revenue by Countries (2019-2023)
        6.1.3 China Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        6.1.4 Japan Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        6.1.5 Korea Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        6.1.6 India Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        6.1.7 Southeast Asia Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        6.1.8 Australia Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    6.2 Asia-Pacific Pandemic Influenza Vaccine Sales and Revenue (Value) by Manufacturers (2019-2023)
    6.3 Asia-Pacific Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type (2019-2023)
        6.3.1 Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Type (2019-2023)
        6.3.2 Asia-Pacific Pandemic Influenza Vaccine Revenue and Revenue Share by Type (2019-2023)
    6.4 Asia-Pacific Pandemic Influenza Vaccine Sales and Market Share by Application (2019-2023)

7 North America Pandemic Influenza Vaccine Market Size Categorized by Countries
    7.1 North America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
        7.1.1 North America Pandemic Influenza Vaccine Sales by Countries (2019-2023)
        7.1.2 North America Pandemic Influenza Vaccine Revenue by Countries (2019-2023)
        7.1.3 United States Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        7.1.4 Canada Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        7.1.5 Mexico Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    7.2 North America Pandemic Influenza Vaccine Revenue (Value) by Manufacturers (2019-2023)
    7.3 North America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type (2019-2023)
        7.3.1 North America Pandemic Influenza Vaccine Sales Market Share by Type (2019-2023)
        7.3.2 North America Pandemic Influenza Vaccine Revenue and Revenue Share by Type (2019-2023)
    7.4 North America Pandemic Influenza Vaccine Sales Market Share by Application (2019-2023)

8 South America Pandemic Influenza Vaccine Market Size Categorized by Countries
    8.1 South America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
        8.1.1 South America Pandemic Influenza Vaccine Sales by Countries (2019-2023)
        8.1.2 South America Pandemic Influenza Vaccine Revenue by Countries (2019-2023)
        8.1.3 Brazil Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    8.2 South America Pandemic Influenza Vaccine Revenue (Value) by Manufacturers (2019-2023)
    8.3 South America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type (2019-2023)
        8.3.1 South America Pandemic Influenza Vaccine Sales Market Share by Type (2019-2023)
        8.3.2 South America Pandemic Influenza Vaccine Revenue and Revenue Share by Type (2019-2023)
    8.4 South America Pandemic Influenza Vaccine Sales Market Share by Application (2019-2023)

9 Middle East and Africa Pandemic Influenza Vaccine Market Size Categorized by Countries
    9.1 Middle East and Africa Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Countries (2019-2023)
        9.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries (2019-2023)
        9.1.3 GCC Countries Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        9.1.4 Turkey Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        9.1.5 Egypt Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
        9.1.6 South Africa Pandemic Influenza Vaccine Sales and Growth Rate (2019-2023)
    9.2 Middle East and Africa Pandemic Influenza Vaccine Revenue (Value) by Manufacturers (2019-2023)
    9.3 Middle East and Africa Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Type (2019-2023)
        9.3.2 Middle East and Africa Pandemic Influenza Vaccine Revenue and Revenue Share by Type (2019-2023)
    9.4 Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Application (2019-2023)

10 Global Pandemic Influenza Vaccine Market Segment by Type
    10.1 Global Pandemic Influenza Vaccine Revenue, Sales and Market Share by Type (2019-2023)
        10.1.1 Global Pandemic Influenza Vaccine Sales and Market Share by Type (2019-2023)
        10.1.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Type (2019-2023)
    10.2 Influenza A (H1N1) Vaccines Sales Growth Rate and Price
        10.2.1 Global Influenza A (H1N1) Vaccines Sales Growth Rate (2019-2023)
        10.2.2 Global Influenza A (H1N1) Vaccines Price (2019-2023)
    10.3 Other Sales Growth Rate and Price
        10.3.1 Global Other Sales Growth Rate (2019-2023)
        10.3.2 Global Other Price (2019-2023)

11 Global Pandemic Influenza Vaccine Market Segment by Application
    11.1 Global Pandemic Influenza VaccineSales Market Share by Application (2019-2023)
    11.2 Adult Sales Growth Rate (2019-2023)
    11.3 Paediatric Sales Growth Rate (2019-2023)

12 Market Forecast for Pandemic Influenza Vaccine
    12.1 Global Pandemic Influenza Vaccine Revenue, Sales and Growth Rate (2024-2031)
    12.2 Pandemic Influenza Vaccine Market Forecast by Regions (2024-2031)
        12.2.1 Europe Pandemic Influenza Vaccine Market Forecast (2024-2031)
        12.2.2 APAC Pandemic Influenza Vaccine Market Forecast (2024-2031)
        12.2.3 North America Pandemic Influenza Vaccine Market Forecast (2024-2031)
        12.2.4 South America Pandemic Influenza Vaccine Market Forecast (2024-2031)
        12.2.5 Middle East & Africa Pandemic Influenza Vaccine Market Forecast (2024-2031)
    12.3 Pandemic Influenza Vaccine Market Forecast by Type (2024-2031)
        12.3.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2024-2031)
        12.3.2 Global Pandemic Influenza Vaccine Market Share Forecast by Type (2024-2031)
    12.4 Pandemic Influenza Vaccine Market Forecast by Application (2024-2031)
        12.4.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2024-2031)
        12.4.2 Global Pandemic Influenza Vaccine Market Share Forecast by Application (2024-2031)

13 Analysis of Pandemic Influenza Vaccine Industry Key Manufacturers
    13.1 AstraZeneca
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 AstraZeneca Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 AstraZeneca News
    13.2 GlaxoSmithKline
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 GlaxoSmithKline News
    13.3 Novartis
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Novartis Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 Novartis News
    13.4 Sanofi
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Sanofi Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Sanofi News
    13.5 Valneva
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Valneva Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Valneva News
    13.6 Lupin
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Lupin Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 Lupin News
    13.7 Chiron Panacea
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Chiron Panacea Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 Chiron Panacea News
    13.8 Solvay and Serum Institute of India Pvt. Ltd.
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 Solvay and Serum Institute of India Pvt. Ltd. News
    13.9 Sementis
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Sementis Pandemic Influenza Vaccine Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 Sementis News

14 Research Findings and Conclusion

15 Appendix

Search results for Pharmaceutical Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Healthcare IT

Biotechnology

Automobile and Transportation

Top Rated Products